• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24125 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2013     Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: national population screening programme for bowel cancer
2013     Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: noninvasive prenatal test for increased risk of trisomy
2011     Health Council of the Netherlands Gezondheidsraad (GR) Population screening act: prostate cancer screening using MRI
2015     Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: risk stratification based on familial risk of bowel cancer
2014     Health Council of the Netherlands Gezondheidsraad (GR) Population screening act: study into self-sampling as primary screening for cervical cancer
2015     Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: study of faecal tests within the population based screening programme for colorectal cancer
2012     Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: tuberculosis screening
2014     Health Council of the Netherlands Gezondheidsraad (GR) Population screening for breast cancer: expectations and developments
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Population screening for primary open-angle glaucoma
2008     University of York Population tobacco control interventions and their effects on social inequalities in smoking
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Population-based colorectal cancer screening: guidelines
2010     Medical Advisory Secretariat (MAS) Population-based strategies for smoking cessation
2015     NIHR Public Health Research (PHR) programme Population-level susceptibility, severity and spread of pandemic influenza: design of, and initial results from, a pre-pandemic and hibernating pandemic phase study using cross-sectional data from the Health Survey for England (HSE)
2003     NIHR Horizon Scanning Centre (NIHR HSC) Porfimer sodium photodynamic therapy for high-grade dysplasia of Barrett's oesophagus - horizon scanning review
2010     Quality Improvement Scotland (NHS QIS ) Portable bladder ultrasound scanners
2006     Medical Advisory Secretariat (MAS) Portable bladder ultrasound: an evidence-based analysis
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable bone mineral density scanners for screening and diagnosis of osteoporosis: uses, limitations, and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable bone mineral density scanners: a review of the clinical effectiveness
2003     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Portable coagulometers: revision of the scientific evidence and economic assessment of their use in self-control of oral anticoagulant treatment
2010     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Portable computed tomography (CT) for the study of diagnostic imaging in specialised areas or setting
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Portable home hemodialysis
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable home hemodialysis for kidney failure
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable monitoring devices for diagnosis of obstructive sleep apnea at home: review of accuracy, cost effectiveness, guidelines, and coverage in Canada
2020     Ontario Health Portable Normothermic Cardiac Perfusion System in Donation After Cardiocirculatory Death: A Health Technology Assessment
2014     HAYES, Inc. Portable pneumatic compression versus low-molecular-weight heparin for prevention of deep vein thrombosis after lower-extremity joint arthroplasty
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable ultrasonography in small emergency departments: a systematic review of the guidelines and clinical-effectiveness
2003     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Portable ultrasound - systematic review, expert panel
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable ultrasound devices for obstetrical or prenatal assessment in rural or remote settings: a review of the diagnostic accuracy
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Portable ultrasound devices in emergency departments
2018     Health Quality Ontario (HQO) Portable ultraviolet light surface-disinfecting devices for prevention of hospital-acquired infections: a healthtechnology assessment
2018     Health Quality Ontario (HQO) Portable ultraviolet light surface-disinfecting devices for prevention of hospital-acquired infections: OHTAC recommendation
2014     HAYES, Inc. Portable versus non-portable intermittent pneumatic compression for prevention of postoperative deep vein thrombosis
2011     HAYES, Inc. Portal vein embolization for liver regeneration followed by staged hepatectomy for cholangiocarcinoma
2011     HAYES, Inc. Portal vein embolization for liver regeneration followed by staged hepatectomy for cholangiocarcinoma
2015     Health Quality Ontario (HQO) Positional Magnetic Resonance Imaging for people with Ehlers-Danlos Syndrome or suspected craniovertebral or cervical spine abnormalities: an evidence-based analysis
2015     Health Quality Ontario (HQO) Positional magnetic resonance imaging for people with Ehlers-Danlos syndrome or suspected craniovertebral or cervical spine abnormalities: OHTAC recommendation
2018     NIHR Health Technology Assessment programme Positive behaviour support training for staff for treating challenging behaviour in people with intellectual disabilities: a cluster RCT
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Positive expiratory pressure devices and incentive spirometers for the prevention of pneumonia: comparative clinical effectiveness and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positive versus negative needleless connectors for central venous lines and peripheral lines: a review of the clinical effectiveness and guidelines
2004     Agency for Healthcare Research and Quality (AHRQ) Positron emission testing for six cancers (brain, cervical, small cell lung, ovarian, pancreatic and testicular)
1996     VA Technology Assessment Program (VATAP) Positron emission tomography
2001     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Positron emission tomography
2000     Medical Services Advisory Committee (MSAC) Positron emission tomography
1994     University HealthSystem Consortium (UHC) Positron emission tomography
2001     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Positron emission tomography - the economic efficacy
2000     Hannover Medical School, Medizinische Hochschule Hannover (MHH) Positron emission tomography - the economic efficacy
2001     Agency for Healthcare Research and Quality (AHRQ) Positron emission tomography (FDG) for myocardial viability
2002     Agency for Healthcare Research and Quality (AHRQ) Positron emission tomography (FDG) for soft tissue sarcoma
2000     Norwegian Knowledge Centre for the Health Services (NOKC) Positron emission tomography (PET)
2003     Norwegian Knowledge Centre for the Health Services (NOKC) Positron emission tomography (PET) - diagnostic and clinical use
2003     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Positron emission tomography (PET) - systematic review of efficacy in selective medical indications
2003     Hannover Medical School, Medizinische Hochschule Hannover (MHH) Positron emission tomography (PET) - systematic review of efficacy in selective medical indications
2011     HAYES, Inc. Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for diagnosis and management of soft tissue sarcoma
2013     HAYES, Inc. Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for the posttreatment management of cancer of the head and neck
2010     HAYES, Inc. Positron emission tomography (PET) and combined positron emission tomography-computed tomography (PET-CT) for breast cancer detection
2011     HAYES, Inc. Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for detection of recurrent ovarian cancer
2011     HAYES, Inc. Positron Emission Tomography (PET) and combined Positron Emission Tomography-Computed Tomography (PET-CT) for diagnosis and initial staging of ovarian cancer
2011     NIHR Health Technology Assessment programme Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation
2017     HAYES, Inc. Positron Emission Tomography (PET) for Alzheimer disease
2016     HAYES, Inc. Positron Emission Tomography (PET) for Alzheimer disease
2011     HAYES, Inc. Positron Emission Tomography (PET) for alzheimer's disease
2002     HAYES, Inc. Positron emission tomography (PET) for Alzheimer's disease (AD)
2007     HAYES, Inc. Positron emission tomography (PET) for alzheimer's disease (AD)
2005     HAYES, Inc. Positron emission tomography (PET) for assessing myocardial metabolism
2002     HAYES, Inc. Positron emission tomography (PET) for bone cancer
2003     HAYES, Inc. Positron emission tomography (PET) for breast cancer
2003     HAYES, Inc. Positron emission tomography (PET) for cardiac applications
2001     HAYES, Inc. Positron emission tomography (PET) for central nervous system (CNS) tumors
2000     HAYES, Inc. Positron emission tomography (PET) for colorectal cancer
2009     HAYES, Inc. Positron emission tomography (PET) for diagnosing and staging lung cancer
2006     ECRI Positron emission tomography (PET) for diagnosis and staging of lymphoma
2003     HAYES, Inc. Positron emission tomography (PET) for epilepsy
2004     Medical Services Advisory Committee (MSAC) Positron emission tomography (PET) for epilepsy
2004     HAYES, Inc. Positron emission tomography (PET) for Huntington's disease (HD)
2002     HAYES, Inc. Positron emission tomography (PET) for liver cancer
2002     HAYES, Inc. Positron emission tomography (PET) for lung cancer
2000     HAYES, Inc. Positron emission tomography (PET) for malignant lymphoma
2000     HAYES, Inc. Positron emission tomography (PET) for malignant melanoma
2014     HAYES, Inc. Positron Emission Tomography (PET) for metastatic melanoma
2009     HAYES, Inc. Positron Emission Tomography (PET) for monitoring and prognosis of lung cancer
2001     HAYES, Inc. Positron emission tomography (PET) for non-central nervous system head and neck tumors
2001     HAYES, Inc. Positron emission tomography (PET) for oesophageal cancer
2002     HAYES, Inc. Positron emission tomography (PET) for other malignancies
2001     HAYES, Inc. Positron emission tomography (PET) for ovarian cancer
2001     HAYES, Inc. Positron emission tomography (PET) for pancreatic cancer
2004     HAYES, Inc. Positron emission tomography (PET) for Parkinson's disease
2001     HAYES, Inc. Positron emission tomography (PET) for prostate cancer
2002     HAYES, Inc. Positron emission tomography (PET) for soft-tissue sarcoma
2005     HAYES, Inc. Positron emission tomography (PET) for stroke
2001     HAYES, Inc. Positron emission tomography (PET) for testicular cancer
2010     Medical Advisory Secretariat (MAS) Positron emission tomography (PET) for the assessment of myocardial viability
2003     HAYES, Inc. Positron emission tomography (PET) for thyroid cancer
2009     HAYES, Inc. Positron emission tomography (PET) for treatment planning of lung cancer
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) Positron emission tomography (PET) imaging in cancer management; HTA Advice 2: Positron emission tomography (PET) imaging in cancer management; Understanding HTBS Advice; Use of PET imaging for cancer in Scotland. Amendment to full report published July 2005.
2009     Belgian Health Care Knowledge Centre (KCE) Positron Emission Tomography (PET) in Belgium: an update
1995     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Positron emission tomography (PET) in cardiology. IPE-95/e (Public report)
2001     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Positron emission tomography (PET) in oncology in Catalonia: current state and proposal for monitorisation
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Positron emission tomography (PET) in oncology: a systematic review of clinical effectiveness and indications for use
2008     Medical Services Advisory Committee (MSAC) Positron emission tomography (PET) review: colorectal, melanoma and ovarian cancer
2001     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Positron emission tomography (PET) with 18FDG on clinical oncology. IPE-01/30 (Public report)